PHARMConnect Questions and Answers
The questions and answers below are designed to help answer some common questions on PHARMConnect. Additional information designed to help guide people who are completing an application form is available within the PHARMConnect system in the help boxes, and within the updated guidelines for funding applications to PHARMAC.
What is PHARMConnect?
PHARMConnect is a new online system that provides a set of tools for people to use.
- An online application form so you can submit applications for new medicines online.(external link)
- A new application tracker so you can view information online on the medicines we are currently considering funding on updated application tracker(external link).
What are the benefits of PHARMConnect?
PHARMAC is committed to making our funding application assessment and decision-making processes faster, clearer and simpler. PHARMConnect is a key way we are helping to make these changes.
- The new application tracker will be user-friendly and will automatically update to ensure you are getting the most up-to-date information. It will clearly display where an application is in the PHARMAC process.
- You will easily be able to provide additional information on medicines that we are already considering for funding online.
- You will be able to submit applications for funding online.
- Three application forms are available, each tailored to meet the needs of a certain group. There is a form available for pharmaceutical suppliers, one for clinicians and one for the general public.
Behind the scenes PHARMConnect will also help PHARMAC staff to manage funding applications. This will result in some benefits as it will provide some long-term efficiency gains.
Will PHARMConnect have any effect on my medicines?
No. PHARMConnect is a tool that we use to help us receive and process funding applications, it won’t affect your medicines or which medicines are funded.
Will PHARMConnect change the way PHARMAC makes decisions?
No, PHARMConnect will not result in any changes to the way we make decisions (the PHARMAC process).
Do I have to use PHARMConnect to submit a funding application?
Yes, PHARMAC expects that all funding applications are made using PHARMConnect. Please call our freephone information line on 0800 660 050 (9am to 5pm weekdays, calling from within New Zealand) or email our enquiries team at email@example.com if you are unable to submit an application using PHARMConnect. They will be able to direct your issue to the relevant staff member.
I submitted an application before the PHARMConnect system went live. How will it affect my application?
PHARMConnect will not change the way we assess an application, so your application will undergo the same assessment process. However, as PHARMConnect will be used by staff to manage applications, we will be migrating applications received before the PHARMConnect system across to the new system.
What is a funding application?
A funding Application is a proposal made to PHARMAC to amend the Pharmaceutical Schedule. This is done through either the funding of a pharmaceutical; or by making changes to the funding of a pharmaceutical that is already on the Pharmaceutical Schedule (for example, a proposal to widen or restrict access).
Who can make a funding application?
There are no restrictions on who can make an Application to PHARMAC. Funding applications can be made by pharmaceutical suppliers, health professionals, clinical groups, consumer groups, members of the general public, PHARMAC staff and DHB officials.
How do I make a funding application to PHARMAC?
PHARMAC prefers that funding Applications are made online using PHARMAC’s PHARMConnect system. The PHARMConnect system can be accessed from the PHARMAC website. Funding Application forms are available on PHARMConnect for suppliers, clinicians and members of the general public.
What information will I need to provide in a funding application?
The Application forms within the PHARMConnect system consist of a series of questions. Funding Application forms are available on PHARMConnect for suppliers, clinicians and members of the general public. The questions asked in each of these forms have been tailored for the relevant group. Please see the application form that is relevant to you for a list of questions.
Will the PHARMConnect system be used for funding applications for individual patients?
No – the Named Patient Pharmaceutical Assessment (NPPA) policy that is used to consider funding of medicines for individual patients will not be affected by the introduction of PHARMConnect. Funding applications for individual patients under the NPPA policy will continue to be managed and processed under a separate system.
I need more information on making a funding application, who should I contact?
Clinicians and members of the general public who wish to make a funding application should call our freephone information line on 0800 660 050 (9am to 5pm weekdays, calling from within New Zealand) or email our enquiries team at firstname.lastname@example.org. They will be able to assist with your questions.
Pharmaceutical suppliers should call PHARMAC on +64 4 460 4990 before making an Application for a proposed amendment to the Pharmaceutical Schedule. We will direct you to the relevant Therapeutic Group Manager, who will discuss the nature of the proposed amendment with you. They will confirm what the appropriate procedure is and what information needs to be provided to PHARMAC.
How do I know that the system is safe and secure?
What security measures will be implemented to secure my information?
PHARMAC takes security seriously. A number of different measures will be put in place to ensure confidential information is kept safe. These measures include two-factor authentication at log in, strong password requirements etc.
Supplier organisations will have the ability to appoint their own systems administrator who will be able to grant access to their companies’ applications to relevant staff. In addition, these supplier systems administrators will have the ability to grant full access to an application, or restricted access that will not allow access to sensitive information such as the negotiated price.
PHARMAC staff will not be able to view draft applications, they will only become visible once you have submitted your application.
I work for a pharmaceutical supplier and several of our staff members work collaboratively to produce an application – how will PHARMConnect allow and support this?
PHARMConnect allows multiple people access to an application, so in this way it supports collaborative work.
Will more medicines be funded or will PHARMConnect result in more medicines being funded or a reduction in the time for a medicine to be funded?
The number of medicines that are funded is dependent on the budget that PHARMAC receives to manage, and the timing of when medicines are funded are dependent on a number of variables including clinical advice, the supplier’s requirements, budget and registration. PHARMConnect will not affect this and therefore will not impact the number or timing of the medicines that are funded. However, we anticipate that efficiency gains created as a result of PHARMConnect may result in a medicine completing PHARMACs assessment in a quicker timeframe.
Last updated: 2 April 2020